Integrated DNA Technologies

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified checked Jun 13, 2026

Salary

Not verified

401(k) match

Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Role

Seniority

Mid From the posting source checked Jun 20, 2026

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Company stage

Public-company From the posting source checked Jun 20, 2026

Equity

Offered Verified - SEC 10-K source checked Jun 20, 2026

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Integrated DNA Technologies Careers at Integrated DNA Technologies | Apply Now Careers at IDT Search jobs at IDT → For more than 35 years, IDT has been enabling genomics laboratories with an oligonucleotide manufacturing process unlike anyone else in the industry, with the most advanced synthesis, modification, purification, and quality control capabilities available. Dr. Joseph Walder established IDT in 1987 with a dedication to innovation, the highest standards of quality, and a promise to maintain deep genomics expertise. From this strong foundation, IDT has evolved from a leading oligo manufacturer to a genomics solutions provider supporting key areas such as next generation sequencing, CRISPR, synthetic biology, and PCR, equipping researchers with the right tools when they needed them. With these core efforts, IDT teams have been behind the scenes helping to drive science forward with increased quality, volume, efficiencies, and unmatched customer service. IDT today Technology is evolving faster than ever before. Scientists leading the transition from basic to translational research face new challenges with securing the custom solutions necessary to advance their research out of the lab and into the clinic. These emerging barriers have collectively slowed down critical discoveries with potentially profound impacts on human and ecological health. ​​​​​​​ To help overcome these obstacles and push the boundaries of technology, IDT has expanded production facilities and capabilities to include GMP* and cGMP manufacturing grades. These additions provide customers with a genomics solutions partner capable of supporting the entire research journey. IDT's infrastructure supports customers around the globe with

Read the full description at jobs.danaher.com. FewerJobs shows a preview and links to the original posting.